Pharmaceutical Research and Manufacturers of America & Donald Trump
4 shared events · Importance 3 · Last updated Apr 13, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Domestic
Pharmaceutical Research and Manufacturers of America: The Pharmaceutical Research and Manufacturers of America, a major lobbying group for drug companies, expressed strong opposition to Donald Trump's proposed executive order, stating that 'Government price setting in any form is bad for American patients'.
May 11, 2025 · 6 articles
Regulatory
Pharmaceutical Research and Manufacturers of America: Pharmaceutical Research and Manufacturers of America criticized the new pharmaceutical tariffs, warning they would increase healthcare costs and jeopardize U.S. investments.
Apr 02, 2026 · 23 articles
Domestic
Pharmaceutical Research and Manufacturers of America: Pharmaceutical Research and Manufacturers of America, a trade association for pharmaceutical companies, states that pharmacy benefit managers and insurers create access and affordability barriers for patients.
Apr 02, 2026 · 6 articles
Domestic
Pharmaceutical Research and Manufacturers of America: Pharmaceutical Research and Manufacturers of America, a pharmaceutical company trade group, warned that Donald Trump's proposed tariffs on cutting-edge medicines could increase costs and jeopardize billions in U.S. investments.
Apr 02, 2026 · 16 articles
NEWSDESK
Explore this relationship live
Track how Pharmaceutical Research and Manufacturers of America and Donald Trump interact across events, view sentiment trends, and discover connected entities.
Open Dashboard